TrialJAMA cardiology2021

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial.

Kieran F Docherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.